Standardized OTC labels could minimize line extension confusion -- APhA.
This article was originally published in The Tan Sheet
Executive Summary
STANDARDIZED OTC LABEL COULD HELP TO ELIMINATE LINE EXTENSION CONFUSION, American Pharmaceutical Association (APhA) Board of Trustees member Janet Engle maintained at a Sept. 29 FDA public hearing on OTC labeling. Consumers may "assume that a consistent brand name on an over-the-counter drug product refers to consistent active ingredients," which is not always true "given the trend toward over-the-counter brand name line extensions," Engle said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: